Vertex to buy kidney disease drugmaker Alpine for $4.9B
BioPharma
Source: biopharmadive.com
Page 18 - Alpine Immune Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Alpine Immune Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Alpine Immune Sciences Today - Breaking & Trending Today
Vertex Pharmaceuticals to Acquire Alpine Immune Sciences for $4.9 Billion -- Update
By Ben Glickman Vertex Pharmaceuticals has agreed to acquire Alpine Immune Sciences for $4.9 billion in cash, bolstering its portfolio on kidney diseases as deals in biotechnology continue to...
Source: marketscreener.com
Vertex Pharmaceuticals to buy Alpine Immune Sciences for $4.9 billion
(Reuters) -Vertex Pharmaceuticals will buy Alpine Immune Sciences for about $4.9 billion in cash, gaining access to the biotech firm's treatment for an ...
Source: saltwire.com
Alpine Immune Sciences Shares Rally After Vertex Agrees to Acquire Co.
By Stephen Nakrosis Shares of Alpine Immune Sciences were trading sharply higher in Wednesday's after-hours market, following news Vertex Pharmaceuticals agreed to acquire the company in a...
Source: marketscreener.com
Vertex Pharmaceuticals To Buy Alpine Immune Sciences For $4.9 Bln
Vertex Pharmaceuticals Inc. (VRTX) Wednesday announced that it has agreed to acquire Alpine Immune Sciences Inc. (ALPN), a biotechnology company focused on discovering and developing innovative, protein-based immunotherapies.
Source: rttnews.com